The dopaminergic midbrain participates in human episodic memory formation: evidence from genetic imaging.
Recent data from animal studies raise the possibility that dopaminergic neuromodulation promotes the encoding of novel stimuli. We investigated a possible role for the dopaminergic midbrain in human episodic memory by measuring how polymorphisms in dopamine clearance pathways affect encoding-related brain activity (functional magnetic resonance imaging) in an episodic memory task. In 51 young, healthy adults, successful episodic encoding was associated with activation of the substantia nigra. This midbrain activation was modulated by a functional variable number of tandem repeat (VNTR) polymorphism in the dopamine transporter (DAT1) gene. Despite no differences in memory performance between genotype groups, carriers of the (low expressing) 9-repeat allele of the DAT1 VNTR showed relatively higher midbrain activation when compared with subjects homozygous for the 10-repeat allele, who express DAT1 at higher levels. The catechol-O-methyl transferase (COMT) Val108/158Met polymorphism, which is known to modulate enzyme activity, affected encoding-related activity in the right prefrontal cortex (PFC) and in occipital brain regions but not in the midbrain. Moreover, subjects homozygous for the (low activity) Met allele showed stronger functional coupling between the PFC and the hippocampus during encoding. Our finding that genetic variations in the dopamine clearance pathways affect encoding-related activation patterns in midbrain and PFC provides strong support for a role of dopaminergic neuromodulation in human episodic memory formation. It also supports the hypothesis of anatomically and functionally distinct roles for DAT1 and COMT in dopamine metabolism, with DAT1 modulating rapid, phasic midbrain activity and COMT being particularly involved in prefrontal dopamine clearance.
Schott
Björn H
BH
Department of Neurology II, Center for Advanced Imaging, University Hospital of Magdeburg, 39120 Magdeburg, Germany. bschott@neuro2.med.uni-magdeburg.de
Seidenbecher
Constanze I
CI
Fenker
Daniela B
DB
Lauer
Corinna J
CJ
Bunzeck
Nico
N
Bernstein
Hans-Gert
HG
Tischmeyer
Wolfgang
W
Gundelfinger
Eckart D
ED
Heinze
Hans-Jochen
HJ
Düzel
Emrah
E
D000293:Adolescent; D000328:Adult; D001519:Behavior; D001921:Brain / Q000033:anatomy & histology / Q000502:physiology; D002394:Catechol O-Methyltransferase / Q000235:genetics*; D004298:Dopamine / Q000378:metabolism; D050483:Dopamine Plasma Membrane Transport Proteins / Q000235:genetics* / Q000378:metabolism; D005260:Female; D005838:Genotype; D006624:Hippocampus / Q000378:metabolism / Q000502:physiology; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D008568:Memory / Q000502:physiology*; D011939:Mental Recall; D008636:Mesencephalon / Q000033:anatomy & histology / Q000502:physiology*; D011110:Polymorphism, Genetic; D017397:Prefrontal Cortex / Q000502:physiology; D020080:Tandem Repeat Sequences
D050483:Dopamine Plasma Membrane Transport Proteins; C493214:SLC6A3 protein, human; D002394:Catechol O-Methyltransferase; D004298:Dopamine